Deodato, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 9.683
EU - Europa 6.914
AS - Asia 6.413
SA - Sud America 1.103
Continente sconosciuto - Info sul continente non disponibili 306
AF - Africa 214
OC - Oceania 15
Totale 24.648
Nazione #
US - Stati Uniti d'America 9.381
SG - Singapore 3.056
DE - Germania 2.510
CN - Cina 1.410
SE - Svezia 1.230
BR - Brasile 908
IT - Italia 777
FR - Francia 579
VN - Vietnam 567
UA - Ucraina 519
IN - India 314
GB - Regno Unito 313
IE - Irlanda 279
FI - Finlandia 219
ID - Indonesia 197
CA - Canada 173
JP - Giappone 169
BD - Bangladesh 146
HK - Hong Kong 122
RU - Federazione Russa 118
TR - Turchia 107
AR - Argentina 70
MX - Messico 62
NL - Olanda 59
IQ - Iraq 58
CI - Costa d'Avorio 50
BE - Belgio 49
ZA - Sudafrica 49
PL - Polonia 43
ES - Italia 36
IR - Iran 34
CZ - Repubblica Ceca 32
EC - Ecuador 31
SA - Arabia Saudita 30
AT - Austria 29
MA - Marocco 26
EG - Egitto 24
UZ - Uzbekistan 24
CO - Colombia 22
CL - Cile 20
PH - Filippine 20
PK - Pakistan 20
JM - Giamaica 17
VE - Venezuela 17
KE - Kenya 16
LT - Lituania 16
CH - Svizzera 15
KR - Corea 15
RO - Romania 15
TN - Tunisia 15
NP - Nepal 14
AU - Australia 12
JO - Giordania 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
UY - Uruguay 10
MY - Malesia 9
DK - Danimarca 8
IL - Israele 8
AL - Albania 7
AZ - Azerbaigian 7
CR - Costa Rica 7
DZ - Algeria 7
NI - Nicaragua 7
PE - Perù 7
RS - Serbia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BO - Bolivia 6
GR - Grecia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LK - Sri Lanka 6
EU - Europa 5
HN - Honduras 5
LU - Lussemburgo 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
SI - Slovenia 4
AG - Antigua e Barbuda 3
AO - Angola 3
BH - Bahrain 3
BS - Bahamas 3
BY - Bielorussia 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
Totale 24.306
Città #
Singapore 1.655
Chandler 1.234
Ashburn 858
San Jose 849
Beijing 337
Jacksonville 288
Dublin 276
Los Angeles 265
San Mateo 258
The Dalles 210
New York 209
Ho Chi Minh City 187
Lauterbourg 187
Nanjing 180
Wilmington 175
Jakarta 172
Dearborn 160
Milan 155
Hanoi 151
Boston 139
Tokyo 138
Bremen 125
Nürnberg 114
Frankfurt am Main 107
Munich 105
Hong Kong 104
Woodbridge 104
Marseille 98
São Paulo 98
Ann Arbor 96
Rome 91
Hefei 85
Lawrence 82
Dallas 81
Cattolica 79
Helsinki 79
Princeton 77
Hyderabad 73
Houston 70
Izmir 69
Moscow 68
Nanchang 65
Fairfield 60
Santa Clara 57
Toronto 57
Redwood City 56
Buffalo 55
Seattle 54
Atlanta 53
Chicago 53
Abidjan 50
Orem 50
Brussels 49
Guangzhou 36
St Louis 36
Brooklyn 34
Augusta 33
Leawood 33
University Park 33
Zhengzhou 33
Shanghai 32
Boardman 31
Fremont 31
Kunming 31
Shenyang 31
Düsseldorf 30
London 30
Montreal 30
Paris 30
Phoenixville 29
Norwalk 28
Redmond 28
Stockholm 28
Amsterdam 27
Hebei 26
Tianjin 26
Turku 26
Warsaw 26
Lancaster 25
Council Bluffs 24
Da Nang 24
Memphis 24
Mountain View 24
Jiaxing 23
Detroit 22
Lappeenranta 22
Pune 22
Rio de Janeiro 22
Changsha 21
Mexico City 21
North York 21
Johannesburg 20
Mumbai 20
Nuremberg 20
Phoenix 20
Tashkent 20
Auburn Hills 19
Falls Church 19
Kent 19
San Francisco 19
Totale 11.776
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 302
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 287
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 270
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 233
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 230
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 222
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 220
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 212
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 197
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 197
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 196
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 196
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 195
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 194
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 194
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 194
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 194
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
In Vivo Portal Dosimetry by an Ionization Chamber 190
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 189
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 189
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 188
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 187
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 186
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 185
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 185
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 178
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 177
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 177
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 176
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 176
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 175
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 174
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 174
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 173
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 172
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 172
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 171
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 167
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 166
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 165
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 165
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 165
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 164
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 164
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 162
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 158
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 158
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 158
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 158
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 158
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 156
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 156
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 156
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 156
Adequacy of Pain Management in Patients Referred for Radiation Therapy: A Subanalysis of the Multicenter ARISE-1 Study 154
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 154
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 154
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 152
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 152
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
Further Clarification of Pain Management Complexity in Radiotherapy: Insights from Modern Statistical Approaches 150
Real time transit dosimetry for the breath-hold radiotherapy technique experience 150
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 150
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 148
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 146
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 145
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 145
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 144
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 142
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 141
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 141
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 141
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 140
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 140
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 140
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 140
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 140
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 139
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 139
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 138
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 138
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 138
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 137
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 137
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 136
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 134
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 134
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 132
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 131
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 129
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 129
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 129
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 129
Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model 128
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 127
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 125
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 125
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 125
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 124
Totale 16.514
Categoria #
all - tutte 98.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.374 0 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/20253.078 73 80 208 112 348 76 58 154 527 357 593 492
2025/20268.447 1.229 228 404 757 1.492 485 1.394 508 662 660 342 286
2026/20271.351 463 888 0 0 0 0 0 0 0 0 0 0
Totale 24.648